Boston Scientific (BSX) Free Cash Flow (2009 - 2026)

Boston Scientific has disclosed Free Cash Flow across 18 years of filings, most recently posting $1.3 billion for Q2 2026.

• In Q2 2026, Free Cash Flow rose 13.29% year-over-year to $1.3 billion; the TTM figure through Jun 2026 stood at $3.6 billion (up 4.02% YoY), while the FY2025 annual figure was $3.7 billion, up 38.3% from the prior year.
• Free Cash Flow came in at $1.3 billion for Q2 2026 at Boston Scientific, up from $171.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $1.3 billion in Q2 2026 to a low of -$179.0 million in Q1 2022.
• Average Free Cash Flow over 5 years is $582.4 million, with a median of $555.0 million recorded in 2022.
• Year-over-year, Free Cash Flow plunged 185.65% in 2022 and jumped 2460.0% in 2025.
• Over 5 years, Free Cash Flow stood at $595.0 million in 2022, then gained by 15.97% to $690.0 million in 2023, then surged by 70.87% to $1.2 billion in 2024, then slipped by 14.08% to $1.0 billion in 2025, then advanced by 26.26% to $1.3 billion in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $1.3 billion in Q2 2026, $171.0 million in Q1 2026, and $1.0 billion in Q4 2025.